Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled SyringePRNewsWire • 06/12/23
Endo Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Data Analysis in Peer-Reviewed Urology®PRNewsWire • 06/05/23
Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use VialsPRNewsWire • 05/24/23
Endo Announces Agreement with Slayback Pharma to Distribute Prevduo™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Product in the U.S.PRNewsWire • 04/26/23
Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral SuspensionPRNewsWire • 04/03/23
Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar FibromatosisPRNewsWire • 03/13/23
Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) CapsulesPRNewsWire • 03/10/23
Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's DiseasePRNewsWire • 02/06/23
Endo to Cease Production and Sale of Qwo® (collagenase clostridium histolyticum-aaes)PRNewsWire • 12/06/22
Endo Presents New Qwo® (collagenase clostridium histolyticum-aaes) Data at the American Society for Dermatologic Surgery's Annual MeetingPRNewsWire • 10/07/22
Endo Launches Unscripted Video Series With Real Dupuytren's Contracture PatientsPRNewsWire • 10/05/22